LOAR MATTHEW M
Transactions
14
Companies
4
Filings
11
CIK
0001236260
Recent Transactions
- Award
Employee Stock Option (Right to Buy)
2018-06-20+250,000→ 250,000 total - Award
Employee Stock Option (Right to Buy)
2018-06-20+500,000→ 500,000 total - Purchase
Common Stock A Warrant (Right to Buy)
2018-04-12+125,000→ 125,000 total - Purchase
- Purchase
Common Stock B Warrant (Right to Buy)
2018-04-12+125,000→ 125,000 total - Award
Employee Stock Option (Right to Buy)
2017-01-12$0.38/sh+350,000→ 350,000 total - Award
Employee Stock Option (Right to Buy)
2016-03-21+262,500→ 262,500 total - Award
Employee Stock Option (Right to Buy)
2015-07-20+150,000→ 150,000 total - Disposition to Issuer
- Award
- Purchase
- Award
- Award
- Award
Companies
4Recent Filings
11- 4
LOAR MATTHEW M
Jun 22, 2018
- 4
LOAR MATTHEW M
Apr 16, 2018
- 4
MATEON THERAPEUTICS INC
Jan 13, 2017
- 4
OXIGENE INC
Mar 23, 2016
- 4
OXIGENE INC
Jul 20, 2015
- 4
Transcept Pharmaceuticals Inc
Oct 30, 2014
- 4
Transcept Pharmaceuticals Inc
Dec 17, 2013
- 4
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
Oct 23, 2008
- 4
GENELABS TECHNOLOGIES INC /CA
Jan 31, 2006
- 4
GENELABS TECHNOLOGIES INC /CA
Jan 31, 2005
- 4
LOAR MATTHEW M
Jan 26, 2004
Address
TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD STE 110
RICHMOND, CA, 94804